Feng Lv
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 12
- Molecular Medicine top 5%
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics 41
- Pharmaceutical Science top 2%
- Immunology top 10%
- Immunotherapy and Immune Responses 10
- Immune cells in cancer 7
-
- Photodynamic Therapy Research Studies 13
-
- Porphyrin and Phthalocyanine Chemistry 10
-
- RNA Interference and Gene Delivery 9
- Extracellular vesicles in disease 6
- Journals
- ACS Applied Materials & Interfaces (5 papers)Colloids and Surfaces B Biointerfaces (4 papers)Chemical Engineering Journal (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Feng Lv
75 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Biomaterials 545
- Molecular Medicine 146
- Biomedical Engineering 1.1k
- Pharmaceutical Science 138
- Immunology 403
Countries citing papers authored by Feng Lv
This map shows the geographic impact of Feng Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Lv more than expected).
Fields of papers citing papers by Feng Lv
This network shows the impact of papers produced by Feng Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Lv. The network helps show where Feng Lv may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Feng Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 4 | |
| 6 | Low molecular weight polysaccharide of Tremella fuciformis exhibits stronger antioxidant and immunomodulatory activities than high molecular weight polysaccharidebreakdown → | 2024 | 43 |
| 7 | 2024 | 1 | |
| 8 | 2022 | 45 | |
| 9 | 2019 | 87 | |
| 10 | 2018 | 19 | |
| 11 | 2018 | 25 | |
| 12 | 2018 | 22 | |
| 13 | 2017 | 19 | |
| 14 | 2017 | 57 | |
| 15 | 2015 | 92 | |
| 16 | 2015 | 46 | |
| 17 | 2013 | 82 | |
| 18 | 2013 | 12 | |
| 19 | 2013 | 31 | |
| 20 | 2013 | 13 |
About Feng Lv
Feng Lv is a scholar working on Biomaterials, Biomedical Engineering and Pharmaceutical Science, having authored 78 papers that have together received 2.3k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (41 papers), Photodynamic Therapy Research Studies (13 papers), Nanoparticle-Based Drug Delivery (12 papers), Immunotherapy and Immune Responses (10 papers), Porphyrin and Phthalocyanine Chemistry (10 papers), RNA Interference and Gene Delivery (9 papers), Immune cells in cancer (7 papers) and Extracellular vesicles in disease (6 papers). The work is most often cited by research in Biomaterials (545 citations), Molecular Medicine (146 citations) and Biomedical Engineering (1.1k citations). Feng Lv has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xia Dong, Tianjun Liu, Dunwan Zhu, Afeng Yang, Chang Wei, Jie Liang, Deling Kong, Lin Mei, Deling Kong and Zhiyong Qian. Their work appears in journals such as ACS Applied Materials & Interfaces, Colloids and Surfaces B Biointerfaces, Chemical Engineering Journal, RSC Advances and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.